PMID- 26082435 OWN - NLM STAT- MEDLINE DCOM- 20160318 LR - 20221015 IS - 1937-9145 (Electronic) IS - 1945-0877 (Print) IS - 1945-0877 (Linking) VI - 8 IP - 381 DP - 2015 Jun 16 TI - Analysis of single-cell cytokine secretion reveals a role for paracrine signaling in coordinating macrophage responses to TLR4 stimulation. PG - ra59 LID - 10.1126/scisignal.aaa2155 [doi] AB - Macrophages not only produce multiple cytokines but also respond to multiple cytokines, which likely shapes the ultimate response of the population. To determine the role of paracrine signaling in shaping the profile of inflammatory cytokines secreted by macrophages in response to stimulation of Toll-like receptor 4 (TLR4) with lipopolysaccharide (LPS), we combined multiplexed, microwell-based measurements of cytokine secretion by single cells with analysis of cytokine secretion by cell populations. Loss of paracrine signaling as a result of cell isolation reduced the secretion by macrophage-like U937 cells and human monocyte-derived macrophages (MDMs) of a subset of LPS-stimulated cytokines, including interleukin-6 (IL-6) and IL-10. Graphical Gaussian modeling (GGM) of the single-cell data defined a regulatory network of paracrine signals, which was validated experimentally in the population through antibody-mediated neutralization of individual cytokines. Tumor necrosis factor-alpha (TNF-alpha) was the most influential cytokine in the GGM network. Paracrine signaling by TNF-alpha secreted from a small subpopulation of "high-secreting" cells was necessary, but not sufficient, for the secretion of large amounts of IL-6 and IL-10 by the cell population. Decreased relative IL-10 secretion by isolated MDMs was linked to increased TNF-alpha secretion, suggesting that inhibition of the inflammatory response also depends on paracrine signaling. Our results reveal a previously uncharacterized role for cell-to-cell communication within a population in coordinating a rapid innate immune response despite underlying cell-to-cell heterogeneity. CI - Copyright (c) 2015, American Association for the Advancement of Science. FAU - Xue, Qiong AU - Xue Q AD - Department of Biomedical Engineering, Yale University, New Haven, CT 06520, USA. FAU - Lu, Yao AU - Lu Y AD - Department of Biomedical Engineering, Yale University, New Haven, CT 06520, USA. FAU - Eisele, Markus R AU - Eisele MR AD - Department of Biomedical Engineering, Yale University, New Haven, CT 06520, USA. Institute for System Dynamics, University of Stuttgart, 70569 Stuttgart, Germany. FAU - Sulistijo, Endah S AU - Sulistijo ES AD - Department of Biomedical Engineering, Yale University, New Haven, CT 06520, USA. FAU - Khan, Nafeesa AU - Khan N AD - Department of Biomedical Engineering, Yale University, New Haven, CT 06520, USA. FAU - Fan, Rong AU - Fan R AD - Department of Biomedical Engineering, Yale University, New Haven, CT 06520, USA. rong.fan@yale.edu kathryn.miller-jensen@yale.edu. FAU - Miller-Jensen, Kathryn AU - Miller-Jensen K AD - Department of Biomedical Engineering, Yale University, New Haven, CT 06520, USA. Department of Molecular, Cellular, and Developmental Biology, Yale University, New Haven, CT 06520, USA. rong.fan@yale.edu kathryn.miller-jensen@yale.edu. LA - eng GR - U01 CA164252/CA/NCI NIH HHS/United States GR - U54 CA143798/CA/NCI NIH HHS/United States GR - U54-CA143798/CA/NCI NIH HHS/United States GR - U01-CA164252/CA/NCI NIH HHS/United States PT - Journal Article PT - Research Support, N.I.H., Extramural DEP - 20150616 PL - United States TA - Sci Signal JT - Science signaling JID - 101465400 RN - 0 (Cytokines) RN - 0 (Lipopolysaccharides) RN - 0 (TLR4 protein, human) RN - 0 (Toll-Like Receptor 4) SB - IM MH - Cytokines/*immunology MH - Humans MH - Lipopolysaccharides/*pharmacology MH - Macrophages/cytology/*immunology MH - Paracrine Communication/*drug effects/immunology MH - Signal Transduction/*drug effects/immunology MH - Toll-Like Receptor 4/agonists/*immunology MH - U937 Cells PMC - PMC5735825 MID - NIHMS922911 COIS- Competing interests: R.F. has substantial financial interests (including equity) in Isoplexis. EDAT- 2015/06/18 06:00 MHDA- 2016/03/19 06:00 PMCR- 2017/12/19 CRDT- 2015/06/18 06:00 PHST- 2015/06/18 06:00 [entrez] PHST- 2015/06/18 06:00 [pubmed] PHST- 2016/03/19 06:00 [medline] PHST- 2017/12/19 00:00 [pmc-release] AID - 8/381/ra59 [pii] AID - 10.1126/scisignal.aaa2155 [doi] PST - epublish SO - Sci Signal. 2015 Jun 16;8(381):ra59. doi: 10.1126/scisignal.aaa2155.